External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data
Crossref DOI link: https://doi.org/10.1007/s00280-023-04558-z
Published Online: 2023-07-06
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kassir, Nastya http://orcid.org/0000-0001-6193-2993
Chan, Phyllis
Dang, Steve
Bruno, René
Text and Data Mining valid from 2023-07-06
Version of Record valid from 2023-07-06
Article History
Received: 13 April 2023
Accepted: 14 June 2023
First Online: 6 July 2023
Declarations
:
: The authors are employees and stockholders of Genentech/Roche.